Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-AM1977X Phase II study in community-acquired pneumonia
jRCT2080222226Phase 2Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lascufloxacin in community-acquired pneumonia (CAP) (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoint: Clinical cure rate at test-of-cure. Started Sep 2013; status: completed.
02
Drugs
lascufloxacin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on jRCT2080222226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222226.